Treace Medical Concepts I... (TMCI)
NASDAQ: TMCI
· Real-Time Price · USD
6.66
-0.02 (-0.30%)
At close: Sep 26, 2025, 3:59 PM
6.66
0.00%
After-hours: Sep 26, 2025, 04:04 PM EDT
-0.30% (1D)
| Bid | 5.96 |
| Market Cap | 420.73M |
| Revenue (ttm) | 213.75M |
| Net Income (ttm) | -49.18M |
| EPS (ttm) | -0.78 |
| PE Ratio (ttm) | -8.54 |
| Forward PE | -9.42 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 7.28 |
| Volume | 189,783 |
| Avg. Volume (20D) | 330,733 |
| Open | 6.67 |
| Previous Close | 6.68 |
| Day's Range | 6.56 - 6.70 |
| 52-Week Range | 4.54 - 10.79 |
| Beta | 0.71 |
| Ex-Dividend Date | n/a |
About TMCI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TMCI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TMCI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsTreace Medical Concepts Inc. is scheduled to release its earnings on
Nov 4, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-9.55%
Treace Medical Concepts shares are trading lower f...
Unlock content with
Pro Subscription
8 months ago
+14.52%
Treace Medical Concepts shares are trading higher after the company announced preliminary Q4 and FY24 revenue results.
3 weeks ago · seekingalpha.com
Treace Medical Concepts, Inc. (TMCI) Investor Day 2025 Call TranscriptTreace Medical Concepts, Inc. (NASDAQ:TMCI ) Investor Day Call September 3, 2025 9:00 AM EDT Company Participants John Treace - Founder, Chairman & CEO Sean Scanlan - Chief Innovation Officer Conferen...
1 month ago · fool.com
Treace Medical (TMCI) Q2 Revenue Up 7%Treace Medical (TMCI) Q2 Revenue Up 7%
